Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy.
about
Spotlight on grazoprevir-elbasvir once-daily combination and its potential in the treatment of hepatitis CHCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b.Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study.Hepatitis C genotype 4: genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia.A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-naïve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus.HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome.[Cost-effectiveness of hepatitis C treatment in slow virologic responders coinfected with HIV].Hepatitis C virus genotyping using an oligonucleotide microarray based on the NS5B sequence.Core amino acid variation at position 110 is associated with sustained virological response in Caucasian patients with chronic hepatitis C virus 1b infection.Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders.Gel-based microarrays in clinical diagnostics in Russia.
P2860
Q26740233-A419E723-AE9C-4148-B6A5-2EC4A8BB29CFQ34479825-AC477953-80DA-45D4-A95D-47611D151748Q36165309-9F4166A3-89AA-4AE3-92F1-E9D659D96B7FQ36702487-9209B4AA-2C24-41FA-B8DF-FB76B357B42CQ39751806-7AC2079A-EB81-4D01-89F2-275B3D41FFC0Q41412082-686EE2A4-4015-4FB8-A42B-06B7D151A9E3Q41658810-5C621CE8-B118-4478-96B4-A5DF2B889666Q41829739-E290DD31-BF59-46D6-8937-249417FF3C43Q42197581-FB8406B4-0A0F-46D7-ACAD-42BDE3242B0FQ43041150-B7472C41-44EA-4243-9706-5FF28709542DQ43172450-2EBCE25A-424D-4960-B04A-14579156A225
P2860
Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Influence of HCV genotype 1 su ...... pha-2a plus ribavirin therapy.
@en
Influence of HCV genotype 1 su ...... pha-2a plus ribavirin therapy.
@nl
type
label
Influence of HCV genotype 1 su ...... pha-2a plus ribavirin therapy.
@en
Influence of HCV genotype 1 su ...... pha-2a plus ribavirin therapy.
@nl
prefLabel
Influence of HCV genotype 1 su ...... pha-2a plus ribavirin therapy.
@en
Influence of HCV genotype 1 su ...... pha-2a plus ribavirin therapy.
@nl
P2093
P2860
P356
P1476
Influence of HCV genotype 1 su ...... pha-2a plus ribavirin therapy.
@en
P2093
E Chatelut
H Desmorat
J J Meurisse
P2860
P304
P356
10.1002/JMV.21976
P577
2011-03-01T00:00:00Z